Is CD34 truly a negative marker for mesenchymal stromal cells?

被引:187
作者
Lin, Ching-Shwun [1 ]
Ning, Hongxiu [1 ]
Lin, Guiting [1 ]
Lue, Tom F. [1 ]
机构
[1] Univ Calif San Francisco, Dept Urol, Sch Med, Knuppe Mol Urol Lab, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
adipose; bone marrow; CD34; mesenchymal stromal cell; mesenchymal stromal cell marker; Stro-1; HEMATOPOIETIC STEM-CELLS; HUMAN ADIPOSE-TISSUE; HUMAN BONE-MARROW; IN-VIVO; ENDOTHELIAL-CELLS; EXPRESSION; MICE; DIFFERENTIATION; PRECURSORS; PHENOTYPE;
D O I
10.3109/14653249.2012.729817
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The prevailing school of thought is that mesenchymal stromal cells (MSC) do not express CD34, and this sets MSC apart from hematopoietic stem cells (HSC), which do express CD34. However, the evidence for MSC being CD34(-) is largely based on cultured MSC, not tissue-resident MSC, and the existence of CD34(-) HSC is in fact well documented. Furthermore, the Stro-1 antibody, which has been used extensively for the identification/isolation of MSC, was generated by using CD34(+) bone marrow cells as immunogen. Thus, neither MSC being CD34(-) nor HSC being CD34(+) is entirely correct. In particular, two studies that analyzed CD34 expression in uncultured human bone marrow nucleated cells found that MSC (BMSC) existed in the CD34(+) fraction. Several studies have also found that freshly isolated adipose-derived MSC (ADSC) express CD34. In addition, all of these ADSC studies and several other MSC studies have observed a disappearance of CD34 expression when the cells are propagated in culture. Thus the available evidence points to CD34 being expressed in tissue-resident MSC, and its negative finding being a consequence of cell culturing.
引用
收藏
页码:1159 / 1163
页数:5
相关论文
共 56 条
[1]  
[Anonymous], 2006, J CELL SCI
[2]   Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection [J].
Baddoo, M ;
Hill, K ;
Wilkinson, R ;
Gaupp, D ;
Hughes, C ;
Kopen, GC ;
Phinney, DG .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (06) :1235-1249
[3]   Beyond mere markers - Functions for CD34 family of sialomucins in hematopoiesis [J].
Barton Furness, Sebastian George ;
McNagny, Kelly .
IMMUNOLOGIC RESEARCH, 2006, 34 (01) :13-32
[4]   A newly discovered class of human hematopoietic cells with SCID-repopulating activity [J].
Bhatia, M ;
Bonnet, D ;
Murdoch, B ;
Gan, OI ;
Dick, JE .
NATURE MEDICINE, 1998, 4 (09) :1038-1045
[5]   Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo [J].
Cao, Y ;
Sun, Z ;
Liao, LM ;
Meng, Y ;
Han, Q ;
Zhao, RCH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 332 (02) :370-379
[6]   Hematopoietic defects in mice lacking the sialomucin CD34 [J].
Cheng, J ;
Baumhueter, S ;
Cacalano, G ;
CarverMoore, K ;
Thibodeaux, H ;
Thomas, R ;
Broxmeyer, HE ;
Cooper, S ;
Hague, N ;
Moore, M ;
Lasky, LA .
BLOOD, 1996, 87 (02) :479-490
[7]   CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization [J].
Copland, Ian ;
Sharma, Kapil ;
Lejeune, Laurence ;
Eliopoulos, Nicoletta ;
Stewart, Duncan ;
Liu, Peter ;
Lachapelle, Kevin ;
Galipeau, Jacques .
EXPERIMENTAL HEMATOLOGY, 2008, 36 (01) :93-103
[8]   The Tunica Adventitia of Human Arteries and Veins As a Source of Mesenchymal Stem Cells [J].
Corselli, Mirko ;
Chen, Chien-Wen ;
Sun, Bin ;
Yap, Solomon ;
Rubin, J. Peter ;
Peault, Bruno .
STEM CELLS AND DEVELOPMENT, 2012, 21 (08) :1299-1308
[9]   Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317
[10]   Functional activity of murine CD34+ and CD34- hematopoietic stem cell populations [J].
Donnelly, DS ;
Zelterman, D ;
Sharkis, S ;
Krause, DS .
EXPERIMENTAL HEMATOLOGY, 1999, 27 (05) :788-796